Dr Mike Leach has developed compounds, known as UoG-alpha and UoG-beta, that can inhibit the multiple cytokine proteins that can cause death by respiratory collapse, following Covid 19 infection. These compounds can be used within a drug therapy to prevent our immune system from disabling the body’s lung function during a cytokine storm; one of the contributing factors in Covid-19 deaths. This treatment could potentially also help protect cancer and organ transplant patients.
Read a selection of case studies from across the University Alliance, spanning skills, innovation, research and community and business engagement. Every year, UA collects hundreds of short case studies from…
Read a selection of 22 case studies from researchers across the UK who are members of our Doctoral Training Alliance. The Doctoral Training Alliance (DTA) was founded by UA to…
Alliance universities are some of the foremost providers of degree apprenticeships, with apprentices studying everything from Nursing, to Quantity Surveying, to Automotive Engineering all the way to Digital Design. This…
